Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.76 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.76 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.76 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.76 |
| ▸ | DPP4 | P27487 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.76 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.76 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.76 |
| ▸ | GAPDH | P04406 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | STAT6 | P42226 | 1/20 | 0.76 |
| ▸ | PI4KA | P42356 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.76 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.76 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.76 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.76 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17440176 | 1.00 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL2040670 | 1.00 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL10997946 | 0.91 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL12963362 | 0.91 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL5024895 | 0.91 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL7803298 | 0.91 | ADORA1 (0.76) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL15788449 | 0.89 | ADORA1 (0.74) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL15338536 | 0.89 | ADORA1 (0.74) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL384075 | 0.89 | ADORA1 (0.74) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL6246363 | 0.89 | ADORA1 (0.74) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024192269-A2 | ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA | THE GENERAL HOSPITAL CORPORATION (US) | 2024-09-19 | — | — | WO | claimed |
| EP-4384614-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | The University of Hong Kong (HK) | 2024-06-19 | — | — | EP | claimed |
| CN-118176298-A | Materials and methods for comprehensive definition of adaptive immune responses | 香港大学 | 2024-06-11 | — | — | CN | claimed |
| CN-117925755-A | Synthesis method of nucleoside intermediate 2' -O-methyl guanosine | 康羽生命科学技术(苏州)有限公司 | 2024-04-26 | — | — | CN | claimed |
| US-20240024243-A1 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | LABORATORY SKIN CARE, INC. | 2024-01-25 | — | — | US | claimed |
| WO-2023016454-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | THE UNIVERSITY OF HONG KONG (CN) | 2023-02-16 | — | — | WO | claimed |
| EP-2316030-B1 | PROTEIN SCREEING METHODS | WAGNER RICHARD W (US) | 2019-08-21 | — | — | EP | claimed |
| CN-109206464-A | A kind of adenosine diphosphate core saccharide compound and preparation method thereof and bioactivity | 北京大学 | 2019-01-15 | — | — | CN | claimed |
| US-9803193-B2 | Protein screening methods | X-BODY, INC. (US) | 2017-10-31 | — | — | US | claimed |
| CN-105658242-A | MRNA therapy for phenylketonuria | 夏尔人类遗传性治疗公司 | 2016-06-08 | — | — | CN | claimed |
| US-20070232560-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2007-10-04 | — | — | US | claimed |
| CN-1320878-C | Topical composition for follicular delivery of an ornithine decarboxylase inhibitor | WOMEN FIRST HEALTHCARE INC (US) | 2007-06-13 | — | — | CN | claimed |
| EP-1765844-A2 | PURINE NUCLEOTIDE DERIVATIVES | Lauras AS (NO) | 2007-03-28 | — | — | EP | claimed |
| US-20060240056-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2006-10-26 | — | — | US | claimed |
| US-20060057583-A1 | Novel compositions and methods for controlling the extendability of various components used in copying or amplification steps | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. | 2006-03-16 | — | — | US | claimed |
| WO-2005123755-A2 | PURINE NUCLEOTIDE DERIVATIVES | LAURAS AS (NO) | 2005-12-29 | — | — | WO | claimed |
| US-6207446-B1 | MICROCHIP ARRAY OF IMMOBILIZED SINGLE-STRANDED NUCLEIC ACIDS WHICH ARE HYBRIDIZED TO RNA-PROTEIN FUSIONS; FUSIONS ARE RNA COVALENTLY BONDED TO 3' END OF PROTEIN THROUGH A PEPTIDE ACCEPTOR; PROTEIN IS ENCODED BY RNA; CYCLES OF SCREENING | THE GENERAL HOSPITAL CORPORATION | 2001-03-27 | — | — | US | claimed |
| EP-0543949-B1 | ENZYMIC ALTERATION OF HAIR GROWTH | HANDELMAN JOSEPH H (US) | 1997-10-22 | — | — | EP | claimed |
| CN-1162316-A | Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids | NOVATIS CO (CH) | 1997-10-15 | — | — | CN | claimed |
| CN-1039422-A | New S-adenosyl methionine decarboxylase inhibitor | MERRELL DOW PHARMA (US) | 1990-02-07 | — | — | CN | claimed |